Department of Surgery, University of Washington, Seattle, WA 98195-6410, USA.
J Vasc Surg. 2011 Jul;54(1):182-191.e24. doi: 10.1016/j.jvs.2010.12.070. Epub 2011 Apr 14.
High blood flow induces neointimal atrophy in polytetrafluoroethylene (PTFE) aortoiliac grafts and a tight external PTFE wrap of the iliac artery induces medial atrophy. In both nonhuman primate models, atrophy with loss of smooth muscle cells and extracellular matrix (ECM) begins at ≤4 days. We hypothesized that matrix loss would be linked to cell death, but the factors and mechanisms involved are not known. The purpose of this study was to determine commonly regulated genes in these two models, which we hypothesized would be a small set of genes that might be key regulators of vascular atrophy.
DNA microarray analysis (Sentrix Human Ref 8; Illumina, San Diego, Calif; ∼23,000 genes) was performed on arterial tissue from the wrap model (n = 9) and graft neointima from the graft model (n = 5) 1 day after wrapping or the switch to high flow, respectively. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was also performed. Expression of this vascular atrophy gene set was also studied after Fas ligand-induced cell death in cultured smooth muscle cells and organ cultured arteries.
Microarray analysis showed 15 genes were regulated in the same direction in both atrophy models: 9 upregulated and 6 downregulated. Seven of nine upregulated genes were confirmed by qRT-PCR in both models. Upregulated genes included the ECM-degrading enzymes ADAMTS4, tissue plasminogen activator (PLAT), and hyaluronidase 2; possible growth regulatory factors, including chromosome 8 open reading frame 4 and leucine-rich repeat family containing 8; a differentiation regulatory factor (musculoskeletal embryonic nuclear protein 1); a dead cell removal factor (ficolin 3); and a prostaglandin transporter (solute carrier organic anion transporter family member 2A1). Five downregulated genes were confirmed but only in one or the other model. Of the seven upregulated genes, ADAMTS4, PLAT, hyaluronidase 2, solute carrier organic anion transporter family member 2A1, leucine-rich repeat family containing 8, and chromosome 8 open reading frame 4 were also upregulated in vitro in cultured smooth muscle cells or cultured iliac artery by treatment with FasL, which causes cell death. However, blockade of caspase activity with Z-VAD inhibited FasL-mediated cell death, but not gene induction.
Seven gene products were upregulated in two distinctly different in vivo nonhuman primate vascular atrophy models. Induction of cell death by FasL in vitro induced six of these genes, including the ECM-degrading factors ADAMTS4, hyaluronidase 2, and PLAT, suggesting a mechanism by which the program of tissue atrophy coordinately removes extracellular matrix as cells die. These genes may be key regulators of vascular atrophy.
血流增加会导致聚四氟乙烯(PTFE)主动脉-髂动脉移植物的新生内膜萎缩,而髂动脉的紧密外部 PTFE 包裹会导致中膜萎缩。在这两种非人类灵长类动物模型中,从第 4 天开始,平滑肌细胞和细胞外基质(ECM)丢失导致的萎缩开始出现。我们假设细胞死亡与基质丢失有关,但目前尚不清楚涉及的因素和机制。本研究的目的是确定这两种模型中共同调节的基因,我们假设这将是一组可能是血管萎缩关键调节剂的少数基因。
对包裹模型(n = 9)和移植物新内膜的 wrap 模型(n = 5)分别在包裹或切换到高流量后的第 1 天的动脉组织进行 DNA 微阵列分析(Sentrix Human Ref 8;Illumina,圣地亚哥,加利福尼亚州;∼23000 个基因)。还进行了定量逆转录聚合酶链反应(qRT-PCR)。在 Fas 配体诱导的平滑肌细胞和器官培养动脉中的细胞死亡后,也研究了这个血管萎缩基因集的表达。
微阵列分析显示,两个萎缩模型中有 15 个基因以相同的方向调节:9 个上调,6 个下调。qRT-PCR 在两种模型中均证实了 9 个上调基因中的 7 个。上调的基因包括 ECM 降解酶 ADAMTS4、组织纤溶酶原激活物(PLAT)和透明质酸酶 2;可能的生长调节因子,包括 8 号染色体开放阅读框 4 和富含亮氨酸重复家族包含 8;分化调节因子(肌骨骼胚胎核蛋白 1);细胞清除因子(ficolin 3);和前列腺素转运蛋白(溶质载体有机阴离子转运体家族成员 2A1)。五个下调基因得到了确认,但仅在一个或另一个模型中得到确认。在 FasL 处理体外培养的平滑肌细胞或培养的髂动脉时,七个上调基因中的五个也上调,FasL 导致细胞死亡。然而,用 Z-VAD 阻断半胱天冬酶活性抑制了 FasL 介导的细胞死亡,但不抑制基因诱导。
在两种截然不同的非人类灵长类动物血管萎缩体内模型中,有七个基因产物上调。FasL 在体外诱导了其中六个基因,包括 ECM 降解因子 ADAMTS4、透明质酸酶 2 和 PLAT,这表明了组织萎缩的程序协同去除细胞死亡时的细胞外基质的机制。这些基因可能是血管萎缩的关键调节剂。